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1. Introduction 
One of the major aims of molecular biology and medical science is to understand disease 
mechanisms. A genetic disorder is a disease caused by abnormalities in genes and 
chromosomes, and researchers often report the identification of disease-relevant genes and 
correlations between phenotypes and genotypes (Butte & Kohane 2006; Lamb 2007; Perez-
Iratxeta et al. 2002, 2005, 2007). 
Omics analysis using microarray, new generation sequencing (NGS) technology, and mass 
spectrometry is widely employed for determining genome sequences and profiling gene 
expression. Changes in gene expression on a genome-wide scale can be detected by omics 
analysis, which provides various types of huge datasets. These data are often archived in 
public databases; nucleotide sequences in the DDBJ/EMBL/GenBank International 
Nucleotide Sequence Database (INSD) (Cochrane et al. 2011), gene expression in Gene 
Expression Omnibus (GEO) (Barrett et al. 2011), and journal articles in MEDLINE. Currently, 
research cannot continue without the use of these databases. In Japan, the Database Center 
for Life Science (DBCLS) has developed infrastructure for researchers to access and easily 
reuse these data by providing index sites such as INSD and GEO yellow pages and by 
constructing a portal site for life science databases and tools. Researchers can easily analyze 
public data in conjunction with their own omics data. 
Here we present an analytical method to clarify the associations between genes and 
diseases. We characterized genes and diseases by assigning a MeSH-controlled vocabulary 
(Nakazato et al. 2008, 2009). Our objective was to help interpret omics data from molecular 
and clinical aspects by comparing these feature profiles. 
2. Omics databases 
2.1 Microarray data and its repository sites 
Microarray technology is one of the most widely employed tools for genome-wide analyses 
of changes in gene expression under various conditions including diseases and drug 
treatments. This approach is also useful for examining genome copy number variations, 
methylation status, and transcription factor binding. 
Microarray data are archived in public databases such as GEO at the National Center for 
Biotechnology Information (NCBI) (Barrett et al. 2011) and ArrayExpress at the European 
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Bioinformatics Institute (EBI) (Parkinson et al. 2011). GEO is a public functional genomics 
data repository that accepts array- and sequence-based data. It has been developed and 
maintained by NCBI since 2000. GEO archives three types of data: datasets derived from 
research projects, samples such as species and cell lines used, and platforms to produce data 
(i.e., chipsets and massively parallel sequencers). GEO contains approximately 22,000 series 
of experiments, approximately 8500 platforms, and approximately 540,000 samples as of 
March 2011. 
GEO data are freely downloadable (http://www.ncbi.nlm.nih.gov/geo/); therefore, 
researchers can utilize the data to perform further analyses and compare their own data as 
omics analysis. However, it is extremely difficult to grasp the GEO archived data because 
experimental conditions referred in each GEO entry are complicated and partially described 
in plain English. 
 
 
Fig. 1. Snapshot of the GEO Overview 
To ease this situation, Dr. Okubo and his colleagues at the National Institute of Genetics 
(Japan) have developed a web service of an index site as a yellow page called the GEO 
Overview (http://lifesciencedb.jp/geo/), which is maintained by DBCLS (Fig. 1). It shows a 
list of project titles with their platforms and data provider names. In the GEO Overview, the 
datasets archived in GEO are categorized and organized by taxonomy (species type) and 
platform (methods or instruments). Researchers can easily refine the results by clicking the 
tabs corresponding to the taxonomy and platform of interest. In addition, the datasets can be 
searched using the search box at the top of the page. Hit data are categorized by histology 
with a hyperlink to the original GEO entry, and total data size is also provided. The GEO 
Overview should be helpful in outlining the abundant amount of gene expression data 
available from GEO. A tutorial movie for the GEO Overview is available on the TogoTV site 
(http://togotv.dbcls.jp/20100816.html). 
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2.2 NGS and its repository sites 
Microarray technology has been widely employed to detect genome-wide gene expression. 
More recently, NGS, also called next-generation sequencing, has been performed for the 
same purpose. NGS is an ultra-high throughput nucleotide sequencing technology that 
drastically reduces the cost and time than previously possible (Shendure & Ji 2008). NGS 
technology has rapidly spread to approach whole-genome sequencing, metagenomics, and 
transcriptomics, and it also applies to epigenetics and genome-wide association study 
(GWAS) (Kahvejian et al. 2008). 
NGS provides a tremendous of captured images and numerous sequence reads (Nat. 
Biotechnol. Editorial Board 2008), and the in-process files require huge amounts of disk 
space. However, NGS data are important for researchers and should be shared as well as 
microarray data in GEO. Thus, the NGS data are also archived in public databases;  
the Sequence Read Archive (SRA) (Leinonen et al. 2011 b) at NCBI, European Nucleotide 
Archive (ENA) (Leinonen et al. 2011 a) at EBI, and DNA Data Bank of Japan (DDBJ)  
Sequence Read Archive (DRA) (Kaminuma et al. 2010) at DDBJ. These databases are an 
archive databank for raw data from NGS, and the data are collaboratively synchronized. 
Researchers can search and download the archived data from the DDBJ site 
(http://trace.ddbj.nig.ac.jp/dra/). 
Downloaded data from the SRA/ENA/DRA sites can be used for genome mapping, 
assembly, and annotation (Kaminuma et al. 2010). DBCLS has developed an index site for 
NGS data, called the Survey of Read Archives (http://sra.dbcls.jp/) as well as the GEO 
Overview site, to make this data more searchable and usable. The deposited NGS data 
contain not only sequence reads but also experimental conditions including project titles, 
species or cell lines, sample names, and sequencing platforms as metadata. The metadata 
consist of six files in XML format: submission, study, experiment, run, sample, and 
analysis. However, each submission does not contain all of these metadata because 
additional experiments or runs to be assigned to a previous project are often performed 
and archived as a new submission. Therefore, we determined the connections among each 
type of corresponding metadata and developed a project list as an index site. We 
attempted to curate the metadata by correcting misspellings and disambiguating spelling 
variations. 
The Survey of Read Archives site provides a list with project titles, sample names, and a 
hyperlink to corresponding experiments and run data. It categorizes the data by study type 
including whole genome sequencing, transcriptome analysis, and metagenomics. 
Furthermore, the archived data are divided by platform and sample taxonomy. Thus, 
researchers can easily obtain final results with corresponding features of interest. The 
Survey of Read Archives site provides NGS statistical data such as the number of projects 
assigned to each study, platforms, and sample taxonomy. Table 1 shows the top ten list of 
NGS statistical data as of March 2011. 
In addition, the Survey of Read Archives site offers a publication list that refers to NGS 
data. We obtained PubMed IDs (PMIDs) cited in the SRA database as reference articles. 
We also extracted hyperlinks and descriptions of SRA IDs from PubMed articles. The 
publication list provides article titles, journals, and project titles. Using this publication 
list, researchers can retrieve NGS data of sufficiently high quality for analysis. Users can 
narrow down the publication list by referring to NGS’s study types, platforms, and 
sample species. 
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Study type 
Study type The number of projects 
Whole genome sequencing 2799 
Transcriptome analysis 778 
Metagenomics 564 
Epigenetics 365 
Resequencing 276 
Other 259 
Population genomics 110 
RNASeq 104 
Gene regulation study 37 
Cancer genomics 18 
  
Platforms 
Platform The number of projects 
Illumina Genome Analyzer II 1628 
454 GS FLX 1209 
454 Titanium 1121 
Illumina Genome Analyzer 753 
454 GS FLX Titanium 274 
GS FLX 150 
GS 20 135 
Unspecified 109 
Illumina HiSeq 2000 99 
454 GS 20 61 
  
Species of samples 
Species The number of projects 
Unidentified 460 
Homo sapiens 414 
Mus musculus 230 
Metagenome sequence 170 
Drosophila melanogaster 149 
Marine metagenome 87 
Caenorhabiditis elegans 75 
Escherichia coli str. K-12 substr. MG1655 66 
Arabidopsis thaliana 55 
Saccharomyces cerevisiae 51 
Table 1. List of top ten study types, platforms, and sample species of NGS data archived in 
SRA databases 
3. Disease database 
3.1 Online Mendelian Inheritance in Man (OMIM) 
OMIM is one of the most widely referred disease databases by biological researchers 
(Amberger et al. 2009; Hamosh et al. 2002, 2005). It contains more than 21,000 detailed entries 
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of genetic diseases and disease-relevant human genes as a knowledge bank. Each disease 
entry provides a full-text overview in some categories including clinical features, diagnoses, 
and pathogenesis, and gene entry consists of sections such as cloning, gene function, and 
allelic variants sections. 
OMIM was originally created as a printed version called the Mendelian Inheritance in Man 
(MIM), which has been annotated by Dr. McKusick and his colleagues for over 40 years 
(McKusick 2007). OMIM, which is the online version of MIM, is accessible through the 
internet from the NCBI site (http://www.ncbi.nlm.nih.gov/omim/). Its contents are the 
copyright of Johns Hopkins University. Data are updated daily on this database, and 
approximately 70 new entries are added per month 
(http://www.ncbi.nlm.nih.gov/Omim/dispupdates.html). The OMIM content is derived 
from the peer-reviewed biomedical literature. 
3.2 Previous work using OMIM data 
OMIM is an excellent resource to obtain information on genetic diseases and disease-
relevant genes and for researchers attempting to understand disease features. Using Entrez 
Gene or Ensembl as a gene database, gene features including gene names, genomic 
locations, and gene ontology (GO) terms can be obtained. However, OMIM is not 
completely exploited for omics analysis because of its bibliographic data structure; it is 
written in plain English (Bajdik et al. 2005). To overcome these difficulties, previous studies 
attempted to extract knowledge described in OMIM and make it easier to use that 
knowledge for biological research, including omics analysis. 
Some groups focused on terms referred in the clinical synopsis (CS) section of OMIM 
(Cantor & Lussier 2004; Freudenberg & Propping 2002; Hishiki et al. 2004; Masseroli et al. 
2005 a; van Driel et al. 2006). The OMIM CS section contains keywords and key phrases for 
the mode of inheritance, symptoms, and phenotypes such as eye color, pain sensitivity, 
height, and weight. 
Table 2 shows a partial list of terms referred in the CS section for Prader–Willi syndrome 
(OMIM ID: 176270) as an example. 
This section describes clinical features of disorders and their modes of inheritance such as 
autosomal dominant, body system such as almond-shaped eyes, and endocrine features 
such as growth hormone deficiency. 
As a previous study, categorization of each OMIM disease entry using particular criteria 
such as episodes, etiology, tissue, onset, and inheritance has been attempted (Freudenberg & 
Propping 2002). They also calculated correlations between OMIM entries on the basis of 
profile similarities. 
Masseroli et al. normalized various descriptions such as Neuro and Neurologic in the CS 
section and characterized OMIM disease entries (Masseroli et al. 2005 a). They developed a 
web service called GFINDer to analyze phenotypes of inherited disorders (Masseroli et al. 
2005 b). 
Cohen et al. also developed a web service to search the OMIM CS section called CSI-OMIM 
(Cohen et al. 2011). 
Using CS terms, researchers can retrieve disease information from OMIM without using 
text-mining techniques. Although the OMIM full-text content includes detailed biological 
and genetic descriptions, the CS terms are mainly clinical and diagnostic, and therefore, it is 
difficult to decipher disease information in conjunction with biological process data such as 
gene expression data. Furthermore, the CS terms such as Cardiac and Cardiovascular are 
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ambiguous because the assigned terms are often defined by the author’s original description 
in the cited articles. We therefore utilized the medical subject headings (MeSH)-controlled 
vocabulary to characterize OMIM entries. 
 
Headings Subheadings Feature 
Inheritance - Isolated cases 
Growth Height Mean adult male height, 155 cm 
  Mean adult female height, 147 cm 
  Steady childhood growth 
 Weight Onset of obesity from 6 months to 6 years 
  Central obesity 
Respiratory - Hypoventilation 
  Hypoxia 
Skeletal - Osteoporosis 
  Osteopenia 
Endocrine features - Hyperinsulinemia 
  Growth hormone deficiency 
  Hypogonadotropic hypogonadism 
Miscellaneous - 
Food related behavioral problems include 
excessive appetite and obsession with eating 
  Temperature instability 
  High pain threshold 
Molecular basis - 
Microdeletion of 15q11 in 70% of patients 
confirmed by fluorescent in situ hybridization 
  Remainder of cases secondary to maternal disomy 
  Rare cases secondary to chromosome translocation 
Table 2. Keywords and key phrases referred in the OMIM CS section for Prader–Willi 
syndrome (partial) 
4. Feature profiling of OMIM data using MeSH keywords 
Many methods such as noise reduction (Li & Wong 2001 a, 2001 b), hierarchical clustering 
(Eisen et al. 1998), and self-organization maps (Tamayo et al. 1999) have been proposed for 
analyzing omics data including microarray. However, these methods are statistical 
approaches, and molecular biology and medicine researchers often need to grasp their 
microarray data from a biological viewpoint. 
Researchers often use a controlled vocabulary, called ontology, to annotate biological 
features including genes. The most popular ontology for biologists is GO (Ashburner et al. 
2000). GO consists of three categories: biological process, molecular function, and cellular 
component. For omics analysis, GO terms are often utilized by assigning corresponding 
terms to genes of interest (Khatri & Draghici 2005; Zeeberg et al. 2003, 2005). However, GO 
cannot be applied to annotate OMIM diseases because it focuses on features at the molecular 
level, and no term corresponding to specific diseases or chemical substance exists. 
Here we introduce MeSH terms to characterize genes and diseases. 
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4.1 MeSH 
MeSH (http://www.nlm.nih.gov/mesh/) is a controlled vocabulary and contains more 
than 23,000 keywords (Nelson et al. 2004). These keywords are hierarchically categorized 
into 15 concepts such as disease, chemicals and drugs, and anatomy. MeSH was originally 
curated for indexing MEDLINE articles by the National Library of Medicine (NLM). 
Researchers can view MeSH keywords assigned to each MEDLINE article in PubMed 
results. In a PubMed search, some queries are automatically added by corresponding MeSH 
terms, and PubMed is searched by a converted query. PubMed also accepts MeSH 
keywords as an input query. MeSH has over 177,000 entry terms that assist in finding the 
most appropriate MeSH heading. For example, vitamin C is an entry term for ascorbic acid. 
In addition, another approximately 200,000 terms of chemical compounds and proteins are 
available as the Substance Names. MeSH is freely on the NLM site in XML and ASCII 
formats and is updated annually. 
4.2 Feature profiling of OMIM data 
4.2.1 Data collection 
We retrieved OMIM data available as of January 2010 by downloading them from the NCBI 
FTP site (ftp://ftp.ncbi.nih.gov/repository/OMIM/) and by using the web service with 
Entrez Programming Utilities (eUtils, http://eutils.ncbi.nlm.nih.gov/). We obtained MeSH 
terms (2010 release) from the NLM web site 
(http://www.nlm.nih.gov/mesh/meshhome.html). MEDLINE article data were also 
obtained from NLM. 
4.2.2 Article extraction related to each OMIM entry 
As previously described, MeSH is originally used for keywords to index MEDLINE articles 
and is not directly linked to OMIM entries. Thus, we developed a method to retrieve articles 
referred in each OMIM entry. A schematic view of the pipeline for generating OMIM–PMID 
associations is shown in Fig. 2. The pipeline consists of three steps. 
First, we retrieved PMIDs cited in the OMIM reference section (Fig. 2 a). Alzheimer Disease, 
AD (OMIM ID: 104300) was used as an example, and 191 articles were referred in the OMIM 
reference section as of March 2011. Previous studies also extracted hyperlinks to external 
databases to utilize MeSH terms for interpreting microarray data (Djebbari et al. 2005; Masys 
et al. 2001). 
Next, we retrieved OMIM IDs referred in the Secondary Source ID section of MEDLINE 
articles (Fig. 2 b). We also collected the OMIM ID descriptions from full-text articles by 
searching PubMed Central. IDs of external databases including GenBank and GEO 
referred in full-text articles are often assigned to MEDLINE articles as a Secondary Source 
ID. As of April 2010, 5463 OMIM IDs were assigned to MEDLINE articles as a Secondary 
Source ID. These Secondary Source IDs are assigned by NLM, but not all IDs are 
extracted. 
In the last step, we obtained PMIDs of articles assigned with MeSH terms corresponding to 
each OMIM entry (Fig. 2 c). As described above, MeSH contains disease category terms; 
therefore, there is often a MeSH keyword corresponding to each OMIM entry. For example, 
the OMIM entry for Alzheimer Disease, AD corresponded to the MeSH term Alzheimer 
Disease. 
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Fig. 2. Schematic view of the pipeline for generating pairs of OMIM entries and relevant 
PMIDs 
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We also obtained articles referring to human genes. OMIM contains entries describing not 
only genetic diseases but also disease-relevant human genes. By obtaining articles related to 
each OMIM entry using these steps, we also obtained articles on human genes. To 
complement articles on human genes, we obtained articles using Entrez Gene as a gene 
database. Using the process described above, we obtained PMIDs referred in Entrez Gene, 
describing Entrez Gene ID in the abstract, and assigned them to corresponding MeSH 
terms. 
Accordingly, we retrieved approximately 500,000 unique pairs of OMIM IDs and PMIDs 
and generated approximately 2,000,000 OMIM–MeSH pairs. 
In a previous version (Nakazato et al. 2008, 2009), we retrieved PMIDs by searching PubMed 
using disease names. To identify contexts indicating genes and diseases from articles is a 
major theme, and many approaches using text mining, such as named entity recognition 
(NER), have been reported (Gaudan et al. 2005; Hirschman et al. 2005; Jensen et al. 2006; 
Shatkay 2005). One of the difficulties is that a single disease often has many names, e.g., type 
2 diabetes, non-insulin dependent diabetes, and NIDDM. Another problem is that the 
same abbreviation may refer to several diseases, genes, or drugs; e.g., EVA refers to 
enlarged vestibular aqueduct (disease), epithelial V-like antigen (gene), and ethylene 
vinyl acetate (chemical). Thus, we attempted to overcome this by creating 
abbreviations/long-form pairs for disease names, such as PWS and Prader–Willi 
syndrome, and searched MEDLINE for articles co-occurring with both names. However, 
this text-mining approach is noisy, and therefore, we discontinued applying this step in 
this version of data creation. 
4.2.3 Scoring associations between OMIM entries and MeSH terms 
OMIM contains gene entries as molecular mechanisms and disease entries as their 
phenotypes (Amberger et al. 2009). We calculated the scores of diseases and genes 
separately. These types are indicated by symbols prefixed to the OMIM ID such as #143100 
(Huntington Disease; HD) and *613004 (Huntingtin; HTT). We divided the OMIM entries 
into three groups according to these types: sequence known (*, +), locus known (%), and 
phenotype (#, none). We then calculated p values as scores of OMIM–MeSH pairs in each 
group. The p value is the probability of the actual or a more extreme outcome under the null 
hypothesis. A lower p value means a larger significance of association. We used R language 
to calculate the p values. 
4.2.4 Data visualization 
To visualize retrieved features of OMIM disease entries with relevant MeSH terms, we 
developed a web-based software application called the gene disease features ontology-based 
overview system (Gendoo) (Nakazato et al. 2008, 2009). Gendoo accepts OMIM IDs, OMIM 
titles, Entrez Gene IDs, gene names, and MeSH terms as input queries. For disease names, 
Gendoo currently uses descriptions of title, alternative titles, and symbols referred in 
OMIM, and therefore, not all synonyms are included in the disease name dictionary. We 
will increase the number of synonyms by adding the canonical name and synonyms (entry 
terms) for corresponding MeSH terms and by extracting disease names from MEDLINE and 
OMIM resources using text mining. Gendoo generates high-scoring lists that display 
relevant MeSH terms for diseases, drugs, biological phenomena, and anatomy together with 
their scores. These MeSH terms are sorted according to their scores. The background color 
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of each association indicates its p value. Gendoo also provides a hierarchical tree view of 
MeSH terms associated with diseases of interest using JavaScript and cascading style sheet 
(CSS) resources from the Yahoo! User Interface (YUI) library 
(http://developer.yahoo.com/yui/). 
Gendoo can be openly accessed at http://gendoo.dbcls.jp/. Every association file including 
Entrez Gene/OMIM IDs, MeSH, and their scores is available from the web site. Dictionary 
files including gene/disease names, synonyms, and IDs are also downloadable. These web 
services and files are freely available under a Creative Commons Attribution 2.1 Japan 
license (http://creativecommons.org/licenses/by/2.1/jp/deed.en). 
4.3 Obtained feature profiles 
4.3.1 Example 1: Positive control 
Table 3 shows a list of scores and MeSH terms closely associated with Alzheimer Disease, 
AD (OMIM ID: 104300) and Amyloid Beta A4 Precursor Protein, APP (OMIM ID: 104760) as 
a positive control. 
 
Alzheimer Disease; AD 
MeSH terms Category p value 
Alzheimer Disease Disease 0 
Amyloid Beta Protein Chemicals and Drugs 0 
Brain Anatomy 0 
 
Amyloid Beta A4 Precursor Protein; APP 
MeSH terms Category p value 
Alzheimer Disease Disease 4.20 × 10−231 
Amyloid Beta Protein Chemicals and drugs 5.12 × 10−214 
Brain Anatomy 7.32 × 10−35 
Table 3. Lists of scores and keywords related to Alzheimer Disease and the Amyloid Beta A4 
Precursor Protein 
Alzheimer disease is a neurodegenerative disorder caused by accumulation of amyloid 
plaques in the brain. Here we used three MeSH terms as keywords to describe features of 
Alzheimer disease: Alzheimer Disease, Amyloid Beta Protein, and Brain. The scores among 
the keywords and the OMIM entry of Alzheimer Disease were small; thus, the retrieved 
associations seemed to properly illustrate features of the disease. The entry of the Amyloid 
Beta A4 Precursor Protein as an example of a gene was also strongly associated with these 
keywords. 
4.3.2 Example 2: Retrieved profile 
Table 4 lists the top three keywords related to Prader–Willi syndrome (OMIM ID: 176270) 
for the features of the fields, such as Diseases, Chemicals and Drugs, Biological Phenomena, 
and Anatomy, as examples of retrieved profiles. 
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Prader–Willi syndrome results from deletion of paternal copies of the imprinted small 
nuclear ribonucleoprotein polypeptide N (SNRPN) and necdin genes within chromosome 15 
(Horsthemke & Wagstaff 2008). The results showed that the keyword clearly reflected the 
features of Prader–Willi syndrome, including Chromosomes, Human, Pair 15, Genomic 
Imprinting, and Ribonucleoproteins, Small Nuclear. For the features of Prader–Willi 
syndrome, the OMIM CS section presents morphologies and clinical and diagnostic fields 
such as mean height and temperature instability (Table 2). This approach illustrates the 
disease features from a clinical and biological perspective. To retrieve more clinical and 
diagnostic features with MeSH, we increased the number of novel associations using terms 
from the MeSH category Analytical, Diagnostic, and Therapeutic Techniques and 
Equipment. 
 
MeSH category MeSH terms p value 
Diseases Prader–Willi syndrome 0 
 Angelman syndrome 4.05 × 10−140 
 Obesity 6.94 × 10−128 
Chemicals and Drugs Human growth hormone 5.86 × 10−68 
 Ribonucleoproteins, small nuclear 4.29 × 10−62 
 Ghrelin 1.58 × 10−50 
Biological Phenomena Chromosomes, human, pair 15 0 
 Genomic imprinting 2.47 × 10−131 
 Obesity 1.69 × 10−121 
Anatomy Chromosomes, human, pair 15 0 
 Chromosomes, human, 13–15 1.25 × 10−30 
 Adipose tissue 3.93 × 10−13 
Table 4. List of top three keywords related to Prader–Willi syndrome 
4.3.3 Example 3: Comparison of profiles between diseases 
We applied this analysis to types 1 and 2 diabetes mellitus (OMIM IDs 222100 and 125853, 
respectively). Figure 3 shows a summary of typical features and their scores for type 1  
and 2 diabetes mellitus. Each cell color on the heat map reflects the p value of the 
association. 
Figure 3 summarizes the feature profiles; only type 1 diabetes mellitus was closely related 
to Autoimmune Diseases and Spleen (their p values were 4.55 × 10−5 and 5.53 × 10−7, 
respectively), whereas type 2 diabetes was associated with Obesity (p value = 1.18 × 10−15) 
and Adipocytes (p value = 5.17 × 10−5). Type 1 diabetes mellitus involves the immune 
system, whereas type 2 diabetes mellitus is a metabolic disorder (Rother 2007). These 
retrieved profiles reflect the biological features of the diseases. This result suggests that 
MeSH profiles can clarify the differences and similarities in features between OMIM 
entries. 
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Fig. 3. Differences and similarities between feature profiles of type 1 and 2 diabetes mellitus. 
DM, diabetes mellitus 
5. Discussion 
Diverse types of life science data are available including nucleotide sequences at the 
molecular level and clinical records at the individual level. Omics analysis makes it easy to 
detect genome-wide upregulation and downregulation of gene expression under various 
conditions. We analyzed these raw data using several approaches such as statistical 
clustering and pathway analysis. In addition, to decipher phenotype information in 
conjunction with molecular data, we often relate genes that drastically change their 
expression levels to diseases as a result of omics analysis. However, molecular biologists 
only understand mechanisms for specific diseases. Although OMIM is an excellent 
knowledge bank for various diseases, it is not completely exploited for omics analysis 
because of the bibliographic data structure of OMIM. Moreover, drug information is not 
linked to elements associated with diseases and genes of interest. To alleviate this problem, 
we comprehensively characterized diseases and genes referred in OMIM with MeSH-
controlled vocabulary. MeSH profiles allow disease features to be shared and compared. 
Using GO terms, researchers can decipher their omics data from a molecular viewpoint. The 
developed feature profiles illustrate related diseases and drugs. We could obtain more 
clinical and medical data using these MeSH profiles. 
Furthermore, the profiles can be applied to analyses of disease-relevant genes by comparing 
the similarities among profiles of OMIM entries and groups of genes such as those found in 
MeSH keywords
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the gene expression clustering results. Researchers can also obtain overviews of the features 
of unfamiliar diseases. 
Genetic disease subtype entries are available in OMIM. For example, diabetes mellitus, non-
insulin dependent, 3 (NIDDM3, OMIM ID: 603694) is a genetic subtype of diabetes mellitus, 
non-insulin dependent (NIDDM, OMIM ID: 125853, i.e., type 2 diabetes mellitus), which is 
linked to chromosome 20q12-q13.1. Another genetic type of NIDDM, NIDDM1 (OMIM ID: 
601283), is reportedly linked significantly to chromosome 2q37.3. The differences in the 
clinical features between these two NIDDM genetic types seem to be unclear but the genetic 
mechanisms are probably different. Omics analysis emphasizes these genetic differences. 
The diabetes mellitus entry was missing in OMIM, although the entries diabetes mellitus, 
insulin-dependent (type 1 diabetes mellitus) and diabetes mellitus, non-insulin dependent 
(type 2 diabetes mellitus) were present. We plan to create a dictionary of diseases using not 
only OMIM but also MeSH disease category and ICD-10 terms. 
6. Conclusion 
We characterized diseases and genes by generating feature profiles for associated drugs, 
biological phenomena, and anatomy using MeSH keywords. We developed a web service 
called Gendoo to visualize retrieved profiles. This approach illustrates disease features not 
only from a clinical but also a biological viewpoint. We also clarified the differences and 
similarities between disease features by comparing their profiles. Retrieved feature profiles 
are easy to remix such that Gendoo accelerates the process of omics analysis. 
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